Shares of Compass Therapeutics, Inc. (CMPX) have gained 22.2% over the past four weeks to close the last trading session at $5.01, but there could still be a solid upside left in the stock if short-term price targets of Wall Street analysts are any indication. Going by the price targets, the mean estimate of$12.73 indicates a potential upside of 154.1%.The average comprises 11 short-term price targets ranging from a low of $7.00 to a high of$30.00, with a standard deviation of $7.4. While the lowest estim ...